Prostate Cancer

Screening for prostate cancer can help to check if you have cancer. Your doctor may recommend regular screening starting at age 50, or earlier if you are at higher risk.

Prostate cancer may not cause symptoms at first. Urinary problems are not often a sign of cancer, but of another condition. The following tests help confirm a diagnosis of cancer and also provide information about a cancerous tumor:

• Prostate specific antigen (PSA) testing: PSA is a chemical made by prostate tissue. The PSA level (amount of PSA in the blood) is tested to evaluate a man’s risk. In general, a high or rising PSA level may mean an increased cancer risk. PSA testing is also used to evaluate the success of cancer treatments.
• Core needle biopsy: This test involves taking tissue samples from the prostate to obtain more information about cancer cells. During the test, a small probe is inserted into the rectum as the patient lies on his side. An image of the prostate is displayed on a video monitor. With this image as a guide, the doctor uses a thin needle to remove tiny tissue samples from the prostate. The patient is given medications so he does not feel pain during the test.

Radical (total) prostatectomy is surgery to remove the entire prostate. Your doctor may decide to do a prostatectomy if diagnostic tests show that the cancer is confined to the prostate.

The surgery may be done through several small incisions in the abdomen, a technique called laparoscopy. In many cases, a technique called robotic-assisted laparoscopy is used. The robotic system provides a 3-dimensional view of the inside the body and also assists the surgeon’s hand movements.

In some cases, your surgeon may decide to perform the surgery through a larger incision in the abdomen. This is called the retropubic approach. Alternatively, your doctor may perform the surgery through an incision behind the scrotum. This is called the perineal approach.

The surgeon may remove and check the lymph nodes near the prostate to see if the cancer has spread. If the cancer has spread, the surgeon may decide not to remove the prostate. If the cancer has not spread, the surgeon will remove the prostate, the seminal vesicles and a portion of urethra. Nerve-sparing techniques may be used to help preserve erectile function (the ability to achieve and maintain an erection).

Your surgeon will give you detailed instructions on preparing for surgery. After surgery, you will be told how to care for yourself at home as you recover. Be sure to ask any questions you have about the procedure and recovery.

High-Intensity Focused Ultrasound (HIFU) is a minimally invasive treatment for localized prostate cancer that uses high-frequency sound waves directed at the cancerous tissue through an ultrasound probe inserted into the rectum. The high intensity sound waves heat up and ablate the targeted tissue, causing cell death.

Ochsner Health is using Focal One Robotic HIFU, the world’s most advanced HIFU system, and the only system available to treat prostate cancer patients throughout the Gulf Coast region. With Focal One, high resolution images are fused with biopsy data and real-time ultrasound imaging which allows the urologist to view cancerous tissue images in 3D. With this clear view, the doctor can draw precise contours around the diseased tissue, ablate only that portion of the prostate and minimize damage to surrounding structures, which include nerves, blood vessels and muscle tissue. For the patient, this reduces the risk of urinary incontinence and erectile dysfunction.

Focal One Robotic HIFU gives urologists the ability to use focal therapy to ablate only the diseased portion of the prostate. This is similar to performing a lumpectomy to remove only the diseased tissue from the breast of a woman with breast cancer, and focal therapy still leaves the options of radical surgery or radiation therapy, should the cancer return. Read more about the Focal One HIFU treatment here.

Why is HIFU a good option for prostate cacncer treatment?

For men diagnosed with localized prostate cancer, HIFU provides another alternative between active surveillance, and radical surgery and radiation. HIFU is a minimally invasive, outpatient procedure. No incisions are made during treatment. Think of holding a magnifying glass above a leaf on a sunny day. The sun’s rays shine through the lens and cause the leaf to burn.

Which patients qualify for HIFU?

Ideal candidates for HIFU are those who have early stage (Gleason 6 or 7), low-grade cancer that is confined to the prostate and that is visible on an MRI or ultrasound. A PSA level below 20ng/mL is also preferred. HIFU is used to treat a single tumor or part of a large tumor and is not meant for those whose cancer has spread beyond the prostate.

To schedule an appointment or for more information, please call 504-842-4083.

Pluvicto is a radioactive medication used to treat advanced prostate cancer, a type of prostate cancer that has spread to other parts of the body. Pluvicto won’t cure cancer, but it can help slow tumor growth and spread.

Pluvicto is given through an IV infusion in the arm. It is done once every six weeks for up to six sessions, as long as there are no severe side effects. 

Who is eligible to receive Pluvicto treatment?

Pluvicto is for men whose prostate cancer has spread to other parts of their body and who no longer are responding to hormonal therapies or chemotherapy. It is an option for patients whose cancer has been treated with both a hormone-blocking medicine and a type of anticancer drug called a taxane.

Pluvicto, which is also sold under the name lutetium Lu 177 vipivotide tetraxetan, was approved by the Food and Drug Administration in 2022. 

The prostate is a gland about the size and shape of a walnut. It surrounds the upper part of the urethra in men, the tube that carries urine from the bladder. The prostate is part of the male reproductive system and produces most of the semen in which sperm travel.

As a man ages, his prostate changes. Inside a changing prostate, groups of cells may form tumors or other growths:

• Noncancerous growths. As a man ages, the prostate may grow larger. This condition is called benign prostatic hyperplasia (BPH). Extra prostate tissue often squeezes the urethra, causing symptoms such as difficulty urinating. But BPH does NOT lead to cancer.
• Atypical cells (prostatic intraepithelial neoplasia or PIN). Some cells don’t appear normal, but they are not cancer. These cells may indicate that cancer is present or is likely to form.
• Cancer. Abnormal cells form a tumor—a lump of cells that grow uncontrolled. Cancer may or may not produce symptoms. Some tumors can be felt during a physical exam; others can’t. Prostate cancer can often be cured or controlled, especially if it is found and treated early. Screening tests help detect it before it causes any symptoms.
• Cancer spread. The cancer may spread to nearby organs. In some cases, the cancer spreads to bones or organs in distant parts of the body. This spread is called metastasis.

Risk factors for prostate cancer include the following:

• Age. As you grow older, your risk of developing cancer increases
• Family history. If your father or brother has had this cancer, your risk of developing it is higher
• Race. African-American men are more likely than other men to develop prostate cancer. They are also more likely to die of this disease than other men with prostate cancer.